Skip to content

A Wearable With Photoplethysmography and 6-lead Electrocardiography for Atrial Fibrillation Detection

A Wearable With Photoplethysmography and 6-lead Electrocardiography for Atrial Fibrillation Detection

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04281927
Acronym
DoubleCheckAF
Enrollment
435
Registered
2020-02-24
Start date
2019-03-06
Completion date
2019-11-15
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

wearable, electrocardiography, photoplethysmography

Brief summary

A single center prospective case-control study to evaluate ability of a wearable to differentiate between atrial fibrillation (AF) and sinus rhythm (SR).

Interventions

DEVICEMonitoring with wearable (the tested device) and Holter ECG (eMotion Faros 90)

Participants will use the wearable (the tested device) to record at least 2 minutes of photoplethysmography and 6-lead ECG. In addition, each subject will be monitored with synchronous ECG Holter monitoring (with eMotion Faros 90).

Sponsors

Kaunas University of Technology
CollaboratorOTHER
Vilnius University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Participants with current ECG-based diagnosis of atrial fibrillation, sinus rhythm or sinus rhythm with frequent (at least once in 2 minutes) premature atrial or ventricular contractions. * Age is between 18 - 99.

Exclusion criteria

* Participants who refuse to sign an informed consent. * Participants with atrial fibrillation who are currently in a paced rhythm.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of a wearable system for atrial fibrillation detectionPPG will be assessed in 2 minutes. ECG will be assessed in up to 10 months.The wearable system comprises of two integrated components: a photoplethysmography (PPG) and a 6-lead ECG of the device. It works as described below. First, an automatic PPG algorithm will indicate whether atrial fibrillation is suspected. The rhythm assessment of PPG algorithm is based on pulse regularity. Next, a 6-lead ECG is acquired by the wearable. The rhythm assessment of ECG is based on P waves and regularity of QRS complexes. A diagnosis is made by independent cardiologists. The conclusion of a whole system comprising of both described methods will be compared with a gold standard multi-lead Holter ECG. This standard ECG is also evaluated by independent cardiologists.

Secondary

MeasureTime frameDescription
Diagnostic accuracy of PPG algorithm of the wearable for atrial fibrillation detection2 minutes.An automatic PPG algorithm will indicate whether atrial fibrillation is suspected. The rhythm assessment of PPG algorithm is based on pulse regularity. As a separate diagnostic tool it will be compared with a gold standard multi-lead Holter ECG which is assessed by independent cardiologists.
Diagnostic accuracy of a 6-lead ECG of the wearable for atrial fibrillation detectionUp to 10 months.Independent cardiologists will assess the heart rhythm in a 6-lead ECG acquired by the wearable. As a separate diagnostic tool it will be compared with a gold standard multi-lead Holter ECG which is also assessed by independent cardiologists. The rhythm evaluation of ECG is based on P waves and regularity of QRS complexes.

Countries

Lithuania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026